Influencing the granulocyte function by single perioperative mistletoe extract infusion;Beeinflussung der granulozytenfunktion durch einmalige perioperative mistelextrakt-infusion

Deutsche Zeitschrift fur Onkologie

Volumn 36, Issue 4, 2004, Pages 148-153

  Büssing, Arndt ^a,b   Bischof, M ^b   Hatzmann, W ^c   Bartzsch, F ^c   Soto Vera, D ^d   Fronk, E M ^d   Gmeindl, M ^b   Schietzel, M ^a   Stein, G M ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b Gemeinschaftskrankenhaus Herdecke   (Germany)

^c Marien Hospital Witten   (Germany)

^d Zentrum fur Klinische Forschung   (Germany)

Author keywords

Granulocyte function; Immunomodulation; Infusion; Intravenous application; Mistletoe therapy; Oxidative burst; Viscum album

Indexed keywords

VISCUM ALBUM EXTRACT;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRANULOCYTE FUNCTION; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; PHASE 2 CLINICAL TRIAL; RESPIRATORY BURST; SURGICAL STRESS;

EID: 10944234538     PISSN: 16175891     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-834433     Document Type: Article

References (31)

1. Beilin B, Shavit Y, Cohn S, Kedar E: Narcotic-induced suppression of natural killer cell activity in ventilated and nonventilated rats. Clin Immunol Immunopathol. 1992; 64: 173-176.
2. Berg PA, Stein GM: Does mistletoe therapy influence the defense against epithelial tumors? A critical immunologic analysis. Dtsch Med Wochenschr. 2001; 126: 339-345.
3. Bloksma N, Schmiermann P, de Reuver M, van Dijk H, Willers JM: Stimulation of humoral and cellular immunity by Viscum preparations. Planta Medica. 1982; 4: 221-227.
4. Böcher E, Stumpf C, Bussing A, Schietzel M: Prospektive Bewertung der Toxizität hochdosierter Viscum album L.-Infusionen bei Patienten mit progredienten Malignomen. Zeitschrift für Onkologie. 1996; 28: 97-106.
5. Büssing A, Stumpf C, Stumpf RT, Wutte H, Schietzel M: Therapiebegleitende Untersuchung immunologischer Parameter bei Tumor-Patienten nach hochdosierter intravenöser Applikation von Viscum album L.-Extrakten. Zeitschrift für Onkologie. 1996; 28: 54-59.
6. Büssing A (Ed): Mistletoe. The Genus Viscum. Medicinal and Aromatic Plants - Industrial Profiles. Amsterdam: Harwood Academic Publishers; 2002.
7. Bussing A: Pharmakologische Wirkungen von Mistelextrakten. In: Fintelmann V (Hrsg.): Onkologie auf anthroposophischer Grundlage. Stuttgart: Johannes M. Mayer Verlag; 2002, Kapitel 3.2.4.1, 1-40.
8. Bussing A: Mistel (Viscum album) - anthroposophischer und phytotherapeutischer Ansatz. In: Münstedt K (Hrsg.): Ratgeber unkonventionelle rebstherapien. Landsberg: Ecomed Verlag; 2003, 184-199.
9. Büssing A, Stein GM, Bischof M, Hatzmann W, Bartzsch F, Soto-Vera D, Fronk E.-M., Gmeindl M: Prevention of surgery-induced depression of granulocyte function by intravenous application of a Viscum album L. extract (VA-E). 12. AEK Cancer Congress Würzburg 25.-28. März 2003, Deutsche Krebsgesellschaft, Abstract P-173, S. 167.
10. Carter JJ, Whelan RL: The immunologic consequences of laparoscopy in oncology. Surg Oncol Clin N Am. 2001; 10: 655-677.
11. Costa A, Benedetto V, Ricci C, Merlin P, Borelli P, Fadda E, Fragapane P, Varvello G, Voglino M, de Filippis V: Endocrine, hematological and immunological changes in surgical patients undergoing general anesthesia. Ital J Surg Sci. 1989; 19: 41-49.
12. D'Agostino RB Jr.: Tutorial in Biostatistics: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine. 1998; 17: 2265-2281.
13. Elena G, Amerio N, Ferrero P, Bay ML, Valenti J, Colucci D, Puig NR: Effects of repetitive sevoflurane anaesthesia on immune response, select biochemical parameters and organ histology in mice. Lab Anim. 2003; 37: 193-203.
14. Hajto T: Immunomodulatory effects of iscador: A Viscum album preparation. Oncolog. 1986; 43 suppl 1: 51-65.
15. Hajto T, Hostanska, Frey K, Rordorf C, Gabius HJ: Increased secretion of tumour necrosis factor □, interleukin 1, and interleukin 6 by human mononuclear cells exposed to □-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res. 1990; 50: 3322-3326.
16. Kienle GS, Kienle H: Die Mistel in der Onkologie. Fakten und konzeptionelle Grundlagen. Stuttgart: Schattauer; 2003.
17. Lewis RE, Cruse JM, Hazelwood J: Halothane-induced suppression of cell-mediated immunity in normal and tumor-bearing C3Hf/He mice. Anesth Analg. 1980; 59: 666-671.
18. Lovett EJ, Alderman J, Munster E, Lundy J: Suppressive effects of thiopental and halothane on specific arms of the immune response. J Surg Oncol. 1980; 15: 327-334.
19. Lundy J, Lovett EJ, Hamilton S, Conran P: Halothane, surgery, immunosuppression and artificial pulmonary metastases. Cancer. 1978; 41: 827-830.
20. Lundy J: Anesthesia and surgery: a double-edged sword for the cancer patient. J Surg Oncol. 1980; 14: 61-65.
21. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S: Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003; 97: 1331-1339.
22. Mengs U, Weber K, Schwarz T, Hajto T, Hostanska K, Lentzen H: Effects of the standardized mistletoe preparation Lektinol on granulopoiesis and pulmonary metastases in mice. In: Bardocz S, Pfüller U, Pusztai A (eds): COST 98. Effects of antinutrients on the nutritional value of legume diets, Vol. 5. Luxembourg: Office for Official Publications of the European Communites; 1998, 194-201.
23. Ogawa K, Hirai M, Katsube T, Murayama M, Hamaguchi K, Shimakawa T, Naritake Y, Hosokawa T, Kajiwara T: Suppression of cellular immunity by surgical stress. Surgery. 2000; 127: 329-336.
24. Puig NR, Ferrero P, Bay ML, Hidalgo G, Valenti J, Amerio N, Elena G: Effects of sevoflurane general anesthesia: immunological studies in mice. Int Immunopharmacol. 2002; 2: 95-104.
25. Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika. 1983; 70: 41-55.
26. Rubin DB, Thomas N: Matching using estimated propensity scores; relating theory to practice. Biometrics. 1996; 52: 249-264.
27. Stein GM, Schaller G, Pfüller U, Wagner M, Wagner B, Schietzel M, Bussing A: Characterisation of granulocyte stimulation by thionins from European mistletoe and from wheat. Biochim Biophys Acta. 1999a; 1426: 80-90.
28. Stein GM, Schaller G, Pfüller U, Schietzel M, Büssing A: Thionins from Viscum album L: Influence of viscotoxins on the activation of granulocytes. Anticancer Res. 1999b; 19: 1037-1042.
29. Tashiro T, Yamamori H, Takagi K, Hayashi N, Furukawa K, Nitta H, Toyoda Y, Sano W, Itabashi T, Nishiya K, Hirano J, Nakajima N: Changes in immune function following surgery for esophageal carcinoma. Nutrition. 1999; 15: 760-766.
30. Weber K, Mengs U, Schwarz T, Hajto T, Hostanska K, Allen TR, Weyhenmeyer R, Lentzen H: Effects of a standardized mistletoe peparation on metastatic B16 melanoma colonization in murine lungs. Arzneim.-Forsch./Drug Res. 1998; 48: 497-502.
31. Zschiesche W: Die Wirkung von Iscador auf die Phagozytoseaktivität des dreticulohistiozytären Systems. Monatsbericht der Deutschen Akademie der Wissenschaften. 1966; 8: 750.